Switching wearable sensors mid-study remains a risk for researchers, leading to potential disruption of data continuity. Our latest webinar navigates sensor upgrades without compromising longitudinal data compatibility. Access on-demand: hubs.la/Q04srP6t0 #Wearable #Sensors #AcademicResearch

In neuromuscular diseases like ALS and Duchenne muscular dystrophy (DMD), capturing continuous data across full disease progression can be complex. Ametris delivers a suite of digital endpoints designed for neuromuscular disorder populations. 💡Book a 30-min call: ametris.com/biotech/nmd

Last chance to register for our webinar tomorrow at 12pm EST: Achieving Data Compatibility and Navigating Hardware Evolution Across Sensor Generations with Confidence Register now to receive the recording after: hubs.la/Q04qT1Sd0 #actigraphy #wearables #healthtech #data

Achieving Data Compatibility and Navigating Hardware Evolution Across Sensor Generations with Confidence | Ametris

Explore data-driven health insights with 'Digital Health Monthly' webinar series. Join expert panels to uncover digital health advancements. Register now!

hubs.la

Our team presented at this year’s International Conference on Ambulatory Monitoring of Physical Activity and Movement (ICAMPAM). Read the latest research highlights demonstrating analytical validation across physical activity measures. blog.ametris.com/measures-in-... #Wearable

Measures in Motion: Demonstrating Analytical Validation Results at ICAMPAM 2026

Discover how Ametris validated wearable sensors for chronic heart failure and heart rate monitoring, ensuring accuracy in real-world conditions.

blog.ametris.com

Join us for our upcoming DHM webinar on July 28: Achieving Data Compatibility and Navigating Hardware Evolution Across Sensor Generations with Confidence Secure your spot: hubs.la/Q04nXyTL0

Achieving Data Compatibility and Navigating Hardware Evolution Across Sensor Generations with Confidence | Ametris

Explore data-driven health insights with 'Digital Health Monthly' webinar series. Join expert panels to uncover digital health advancements. Register now!

hubs.la

Ametris Senior Data Scientist Michael Pettinati, PhD breaks down the monitoring landscape and makes the case for continuous wearable assessment in AFib clinical research. 👉 Read: Monitoring Atrial Fibrillation in Clinical Research: The Case for Continuous Wearable Assessment hubs.la/Q04nMyd90

Monitoring Atrial Fibrillation in Clinical Research: The Case for Continuous Wearable Assessment

Why does standard ECG miss atrial fibrillation in clinical trials? Because AFib is often silent and intermittent, continuous PPG and actigraphy detect paroxysmal and asymptomatic atrial fibrillation t...

hubs.la

Cardiology experts discuss how continuous digital measures are transforming cardiovascular trials – from coronary artery disease, heart failure, and oncology trials. Watch the new on-demand webinar on patient-centric cardiovascular endpoints: hubs.la/Q04nD1M-0

📍 ADDS 2027 is heading back to Atlanta. The Ametris Digital Data Summit returns for its fifth year at the Georgian Terrace Hotel, Feb 8-10 2027. Visit the ADDS 2027 Save the Date page to learn more and subscribe for event updates 👇 #clinicaltrials #digitalhealth adds.ametris.com/2027/save-th...

Join Ametris on Monday, June 29, 2026, at 12:00 PM ET to explore how sensor-enabled DHTs are transforming the future of cardiovascular research, drug development, and trial design. Webinar: ametris.com/digital-heal... #cardiology #heartfailure #wearables #healthtech

Building Patient-Centric Cardiovascular Endpoints with Continuous Digital Measures | Ametris

Explore data-driven health insights with 'Digital Health Monthly' webinar series. Join expert panels to uncover digital health advancements. Register now!

ametris.com

AI is rapidly transforming clinical research. At the recent ADDS 2026 scientific conference, a focused session featuring experts & scientists showcased how AI and machine learning is advancing digital health. Sign up to watch on demand now: adds.ametris.com/2026/atlanta...

In our latest webinar, experts discuss how continuous remote monitoring and pre-competitive collaboration could expand safe outpatient immunotherapy administration for oncology patients. 🎥 Watch the on-demand webinar: ametris.com/digital-heal...

Join us on in 1 week on Wednesday, May 27th from 12-1pm EST for our next Digital Health Monthly webinar, "Scaling Access to Immunotherapy Treatments Through Pre-Competitive Collaboration: Introducing the DECODE CRS Coalition" Register here: hubs.la/Q04h6TYr0

With flexible monitoring approaches tailored to different study goals and operational needs, Ametris’ ActiTrack adherence solutions help study teams proactively identify risks, intervene when needed, and maximize data completeness. See our Adherence Monitoring Solutions: hubs.la/Q04h2b0M0

Join the Ametris team at the American College of Sports Medicine 2026 in Salt Lake City, Utah on May 26-29! If you'll be attending #ACSM2026, we'd love to discuss how our wearable technology solutions can help you achieve your research objectives. ametris.com/schedule-mee...

An Exciting New Chapter for Digital Health in Clinical Research! Today, we’re proud to share that Ametris is now a Signant Health company. Read the full announcement to learn more: blog.ametris.com/news/signant...

Signant Health Acquires Ametris to Create an End-to-End eCOA and Wearables Platform

This pre-competitive coalition aims to broaden access to immunotherapies by enabling remote monitoring of common adverse events like CRS.

hubs.la

In a Phase 3 LIBERTAS trial for metastatic castration-sensitive prostate cancer (mCSPC), J&J Innovative Medicine achieved nearly 90% wearable adherence over 12+ months of actigraphy monitoring using a real-time, intervention workflow. Check out our new case study: hubs.ly/Q04gcLvg0

Case Study - LIBERTAS | Ametris

In this study, actigraphy devices were used for more than 12 months to continuously measure sleep quality and physical activity as objective proxies for hot flash burden.

hubs.ly

In case you missed last week's webinar on Huntington’s Disease clinical research and digital health technology, watch the on-demand recording with expert-led technical insights: hubs.la/Q04f_4-30

Accelerating Huntington's Disease Research and Drug Development using Digital Health Technologies | Ametris

Explore data-driven health insights with 'Digital Health Monthly' webinar series. Join expert panels to uncover digital health advancements. Watch now!

hubs.la

Join us on Wednesday, May 27th for our next Digital Health Monthly webinar: Scaling Access to Immunotherapy Treatments Through Pre-Competitive Collaboration: Introducing the DECODE CRS Coalition Register now: hubs.la/Q04fRy200 #Immunotherapy #CytokineReleaseSyndrome #CRS

Scaling Access to Immunotherapy Treatments Through Pre-Competitive Collaboration: Introducing the DECODE CRS Coalition | Ametris

Explore data-driven health insights with 'Digital Health Monthly' webinar series. Join expert panels to uncover digital health advancements. Register now!

hubs.la

Watch our latest #DigitalHealth Monthly Webinar on-demand to hear results from the ADDS 2025 #ALS Workshop, details about new digital measures in ALS, and an insightful panel discussion about how to unlock to potential of DHTs to advance ALS clinical trials: ametris.com/digital-heal...

Please join our upcoming #DigitalHealth Monthly webinar - Redefining #ALS Clinical Endpoints: Unlocking the Potential of #DHTs - where a diverse panel of stakeholders will explore strategies for advancing #digitalendpoints in ALS research: ametris.com/digital-heal...

Registration is now open for the Ametris Digital Data Summit 2026! 🚨 NEW THIS YEAR! For select abstracts submitted to the Scientific Poster Session, there will be an opportunity for a short oral presentation (5-7 minutes). We hope to see you in Atlanta! #ADDSATL2026 adds.ametris.com/2026/atlanta...

📣 We're excited to share a new article by Ametris' Chief Scientific Officer, Christine Guo: How AI-Driven Continuous Monitoring Can Improve Management of Immunotherapy-Related Cytokine Release Syndrome in Oncology Patients Read here: www.appliedclinicaltrialsonline.com/view/ai-immu...

How AI-Driven Continuous Monitoring Can Improve Management of Immunotherapy-Related Cytokine Release Syndrome in Oncology Patients | Applied Clinical Trials Online

Remote monitoring solution for cytokine release syndrome paves the way for more consistent patient care, a deeper understanding of immune responses, ultimately widening patient access to life-saving i...

appliedclinicaltrialsonline.com

Register for #DigitalHealth Monthly #webinar THIS THURSDAY, 9/18, to learn about #DECODE #Obesity working group focusing on evidence generation & regulatory engagement to enhance clinical programs with mature assessments of #physicalactivity ➡️https://ametris.com/digital-health-monthly/decode-obesity

📣 Call for Abstracts! We can't wait for the next opportunity to connect with the #digitalhealth community at #ADDSAtlanta2026 on Feb 23-25. We hope you will share your work at the Scientific Poster Session! 📆 Submit your abstract by Friday, October 31st, 2025: adds.ametris.com/2026/atlanta...

Scientific Poster Session | ADDS Atlanta 2026

ADDS Atlanta 2026 Scientific Poster Session!

adds.ametris.com

↪️ #ADDSBasel2025 is right around the corner! Have you secured your ticket? Connect with #digitalhealth researchers to accelerate #DHT adoption in #clinicalresearch. Spots are filling up! Reserve your ticket and register today: adds.ametris.com/2025/basel/h...

New publication from the National Health and #Aging Trends Study (#NHATS) reports that impairment in vision or motor function may be strong indicators of prevalent #dementia in older adults: bmcgeriatr.biomedcentral.com/articles/10....

Association of sensory and motor impairments with dementia: a cross-sectional analysis in US older adults - BMC Geriatrics

Background Impairments in sensory and motor function are common in older adults and have been linked with higher prevalence of dementia. However, their independent associations with dementia have not ...

bmcgeriatr.biomedcentral.com

📑 Are you applying for #grantfunding and using #actigraphy / #wearables / #digitalhealth tech in your study? Check out our new toolkit, Grant Preparation Resources for Wearable-Based Studies, where we gather commonly requested information in one place: landing.ametris.com/grant-toolkit

Grant Toolkit | Ametris

This toolkit is designed to facilitate the application submission process by gathering information in one place for quick and convenient access.

landing.ametris.com

🔎 Have you seen the #ADDSBasel2025 agenda yet? Watch the short video below to hear what makes ADDS such a unique opportunity to bring members of the multidisciplinary #digitalhealth community together in Basel on Sept. 12th! Learn more and register today▶️ adds.ametris.com/2025/basel/h...

🎥 Our latest #DigitalHealth Monthly webinar is available on-demand! Panelists discussed key points & lessons learned based on their experiences with #wearable #DHTs to help researchers submit compelling, high-impact #grantproposals. Watch here▶️https://ametris.com/digital-health-monthly/grant-toolkit

TRACE study found wrist-worn #actigraphy measured walking bouts in patients w/ #Pulmonary Arterial Hypertension correlate with 6MWD & physical impacts of #PAH, speaking to the utility of #digitalmeasures to monitor #exercisecapacity @pvrinstitute.bsky.social onlinelibrary.wiley.com/doi/10.1002/...

Characteristics of Daily Walking Bouts as Valid and Reliable Indicators of Exercise Capacity in Pulmonary Arterial Hypertension: Insights From the Randomized Controlled Study With Selexipag (TRACE)

There is a need for objective, continuous and remote assessment of exercise capacity in patients with pulmonary arterial hypertension (PAH). Using data from the TRACE study, in which 108 adult patien...

onlinelibrary.wiley.com